128 related articles for article (PubMed ID: 38413252)
1. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms.
Nemours S; Armesto M; Arestín M; Manini C; Giustetto D; Sperga M; Pivovarcikova K; Pérez-Montiel D; Hes O; Michal M; López JI; Lawrie CH
Pathology; 2024 Jun; 56(4):493-503. PubMed ID: 38413252
[TBL] [Abstract][Full Text] [Related]
2. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
[TBL] [Abstract][Full Text] [Related]
3. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
[TBL] [Abstract][Full Text] [Related]
4. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
Munari E; Marchionni L; Chitre A; Hayashi M; Martignoni G; Brunelli M; Gobbo S; Argani P; Allaf M; Hoque MO; Netto GJ
Hum Pathol; 2014 Jun; 45(6):1130-8. PubMed ID: 24703100
[TBL] [Abstract][Full Text] [Related]
5. Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma.
Liu Y; Zhang H; Li X; Wang S; Zhang Y; Zhang X; Xu T; Dong Y; Dong L; Zhou L; Yang X; Wang C
Hum Pathol; 2022 Sep; 127():78-85. PubMed ID: 35724772
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
[TBL] [Abstract][Full Text] [Related]
7. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
Lawrie CH; Armesto M; Fernandez-Mercado M; Arestín M; Manterola L; Goicoechea I; Larrea E; Caffarel MM; Araujo AM; Sole C; Sperga M; Alvarado-Cabrero I; Michal M; Hes O; López JI
J Mol Diagn; 2018 Jan; 20(1):34-45. PubMed ID: 29056573
[TBL] [Abstract][Full Text] [Related]
8. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract][Full Text] [Related]
9. Papillary Renal Neoplasm With Reverse Polarity Is Often Cystic: Report of 7 Cases and Review of 93 Cases in the Literature.
Wei S; Kutikov A; Patchefsky AS; Flieder DB; Talarchek JN; Al-Saleem T; Dulaimi E; Uzzo RG; Testa JR; Pei J
Am J Surg Pathol; 2022 Mar; 46(3):336-343. PubMed ID: 34352808
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.
Lawrie CH; Larrea E; Larrinaga G; Goicoechea I; Arestin M; Fernandez-Mercado M; Hes O; Cáceres F; Manterola L; López JI
J Pathol; 2014 Jan; 232(1):32-42. PubMed ID: 24155122
[TBL] [Abstract][Full Text] [Related]
11. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
12. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
[TBL] [Abstract][Full Text] [Related]
13. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei.
Tong K; Zhu W; Fu H; Cao F; Wang S; Zhou W; Liu C; Chen D; Fan S; Hu Z
Histopathology; 2020 Jun; 76(7):1070-1083. PubMed ID: 31997427
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling of Xp11 renal cell carcinoma.
Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
[TBL] [Abstract][Full Text] [Related]
16. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
[TBL] [Abstract][Full Text] [Related]
17. Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease.
Chan E; Stohr BA; Butler RS; Cox RM; Myles JL; Nguyen JK; Przybycin CG; Reynolds JP; Williamson SR; McKenney JK
Am J Surg Pathol; 2022 Mar; 46(3):392-403. PubMed ID: 34881751
[TBL] [Abstract][Full Text] [Related]
18. Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations.
Lee HJ; Shin DH; Park JY; Kim SY; Hwang CS; Lee JH; Kim JY; Sol MY; Nam JK
Diagn Pathol; 2020 Oct; 15(1):123. PubMed ID: 33023600
[TBL] [Abstract][Full Text] [Related]
19. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
[TBL] [Abstract][Full Text] [Related]
20. Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
Castillo VF; Trpkov K; Van der Kwast T; Rotondo F; Hamdani M; Saleeb R
Pathol Int; 2024 Apr; 74(4):222-226. PubMed ID: 38456605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
